Combination of targeted multikinase inhibitor and radioiodine: a new strategy of treatment for advanced differentiated thyroid carcinoma
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 6
Abstract
Advanced differentiated thyroid carcinoma (ADTC) lacks effective treatment options, and has a poor prognosis, which is an urgent clinical problem to be resolved. Targeted multikinase inhibitor(MKI) has been approved for the treatment of radioiodine refractory differentiated thyroid carcinoma, and have recently been recommended as a preoperative neoadjuvant therapy agents for locally ADTC. Although radioiodine therapy is the standard postoperative treatment for ADTC, it has certain limitations. MKI combined with radioiodine therapy is expected to become a new strategy of treatment for ADTC.
Authors and Affiliations
Wei LIU
Keywords
Related Articles
- EP ID EP750924
- DOI 10.16139/j.1007-9610.2023.06.06
- Views 12
- Downloads 0
Analysis and recognition of endoscopic treatment for cholelithiasis from the view of disease of pancreaticobiliary junction
Cholelithiasis is a common disease, which seriously endangers human health. The traditional treatment mainly depended on open cholecystectomy and biliary tract exploration. With the development of minimally invasive tech...
Interpretation of 2023 2nd NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma
Pancreatic adenocarcinoma, a severe digestive malignancy, is characterized by its poor prognosis. The National Comprehensive Cancer Network (NCCN) persistently refines its guidelines, integrating cutting-edge evidence-ba...
<![CDATA[Diagnosis, treatment and full-process surveillance of early rectal cancer]]>
<![CDATA[Early rectal cancer is defined as any size of rectal epithelial tumor with infiltration depth limited to the mucosa and submucosa, regardless of with or without lymph node metastasis. Local resection is one of t...
<![CDATA[Current status and development of laparoscopic hepatectomy]]>
<![CDATA[]]>
Gastric signet ring cell carcinoma: clinicopathology and surgical treatment combined with comprehensive therapy